PRNewsWire - Health

Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10
Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program
Walker Healthforce Successfully Achieves ISO/IEC 27001 Certification
Elanco to Participate in Upcoming Investor Conferences